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Introduction:  
Skull base chondrosarcomas are low-grade, malignant tumors arising from cartilage tissue. 
Intracranial chondrosarcomas are rare tumors comprising only 0.1-0.2% of all brain neoplasms. In 
skull base 2 out of 4 pathologic subtypes occur: conventional chondrosarcoma and mesenchymal 
chondrosarcoma. Although distant metastases are rare, tumors often invade surrounding bone and 
compress critical anatomical structures including internal carotid artery or cranial nerves. Treatment 
involves surgery and adjuvant radiation therapy. Endoscopic transnasal surgery (ETS) gives the most 
direct approach to the tumor in this region. 
Aim of the study:  
Analysis of clinical presentation, safety and early clinical outcomes  of ETS for skull base 
chondrosarcomas. 
Materials and methods:  
This study is a retrospective analysis of patients who underwent surgery for skull base 
chondrosarcoma in our institution between 2010 and 2019. From the total number of 15, 11 patients 
who underwent ETS were included into a retrospective analysis. 
Results:  
More than a half of the group presented with oculomotor deficits  (55%, n =6), 27% with hearing loss, 
10% with  facial paresthesia and 18% of our patients did not have any symptoms. In more than a half 
cases tumors invaded the dura (64%, n=7). In 27% of cases total resection was possible. Symptoms 
subsidence was observed in 45% (n=5) patients and in 45% (n=5) of cases symptoms decreased. 
Majority of neoplasms were histologically grade 2 tumors (64%, n=7). Majority of patients underwent 
adjuvant proton beam therapy (82%, n=9). Recurrence of the tumor after ETS was observed in one 
patient, who did not undergo proton beam therapy previously. 
Conclusion:  
Endoscopic transnasal approach for skull base chondrosarcomas offers maximum safe access for 
biopsy and for resection to alleviate the symptoms. Gross total resection in many cases is not possible 
due to adjacent critical structures. Resection and subsequent proton beam therapy lead to satisfactory 
tumor control without progression. 
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